Prof. Dr. Olçun Ümit ÜNAL

Yayın Ağı

Makaleler 25

1. Leveraging the non-contrast CT component of PET/CT: an AI-driven delta-radiomics approach to monitor treatment response in metastatic breast cancer

Kahraman E. G., ÜNAL O. Ü., TAŞKAYNATAN H., ÖZDEMİR Ö., BUDAK E., SELVER M. A.

BMC Medical Imaging , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Multicenter Real-World Evaluation of Neoadjuvant Carboplatin in Triple-Negative Breast Cancer

Ellez H. İ., ÇalişkanYildirim E., Majidova N., Ağyol Y., SARI M., SEMİZ H. S., et al.

Cancer Medicine , cilt.15, sa.5, 2026 (SCI-Expanded, Scopus)

3. Self-Efficacy and Body Image in Individuals With Colorectal Cancer and Stomas

Çelik A., Çınar D., Çetin A. Ö., ÜNAL O. Ü.

Oncology Nursing Forum , cilt.53, sa.2, 2026 (SCI-Expanded, SSCI, Scopus)

4. Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group

Şahin G., Tüzün E. K., Güzel H. G., Guliyev M., Dişli A. K., YAZICI M., et al.

International Journal of Cancer , cilt.158, sa.4, ss.1067-1079, 2026 (SCI-Expanded, Scopus)

5. Clinicopathologic Features and Postoperative Outcomes of Parotidectomy: A 16-Year Retrospective Cohort Study from a Tertiary Referral Center

Akay S., Yagiz Agayarov O., Semiz V., KÜÇÜK Ü., ARSLAN İ. B., ÜNAL O. Ü., et al.

Diagnostics , cilt.16, sa.2, 2026 (SCI-Expanded, Scopus)

6. Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study

İşleyen Z. S., Ay S., BAYRAM E., Seçmeler Ş., Selvi O., Kılıçkap S., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

7. Clinical and Pathological Characteristics of Breast Cancer Cases with Germline Alterations in Homologous Recombination Defect-associated Genes

Keser M., Özer Kaya Ö., ÖZDEMİR T. R., PALA E. E., ÜNAL O. Ü., Kubat G.

Acta Haematologica Oncologica Turcica , cilt.58, sa.3, ss.226-231, 2025 (Scopus, TRDizin)

8. Basic and combined peripheral biomarkers have no predictive and prognostic value in breast cancer patients undergoing pre-operative systemic therapy Los biomarcadores periféricos básicos y combinados no tienen valor predictivo ni pronóstico en pacientes con cáncer de mama sometidas a terapia sistémica preoperatoria

KARAALİ C., Esin H., PALA E. E., Keser M., ÜNAL O. Ü., ÜREYEN O., et al.

Cirugia y Cirujanos , cilt.93, sa.6, ss.579-589, 2025 (SCI-Expanded, Scopus)

9. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Kahraman S., Erul E., GÜMÜŞAY Ö., GÜVEN D. C., AKSOY S., BAŞARAN G., et al.

Clinical Breast Cancer , cilt.25, sa.5, 2025 (SCI-Expanded, Scopus)

10. Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study

Ozgun A., Mustafayev F. N. A., Dogan I., Vatansever S., Eryilmaz M. K., ERDOĞAN A. P., et al.

Molecular and Clinical Oncology , cilt.22, sa.6, 2025 (ESCI, Scopus)

11. Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)

Majidova N., YASLIKAYA Ş., MILDANOĞLU M. M., Coskun A., Uzundal D. E., ŞAHİN T. K., et al.

Turkish Journal of Gastroenterology , cilt.36, sa.5, ss.293-301, 2025 (SCI-Expanded, Scopus, TRDizin)

12. Germline ATM Variation in a Young Patient Diagnosed with Breast Cancer Presenting with Vaginal Neuroendocrine Carcinoma

Kahraman E. G., Akay S., PALA E. E., ÖZDEMİR T. R., ÜNAL O. Ü.

Journal of Oncological Science , cilt.11, sa.1, ss.58-62, 2025 (Scopus, TRDizin)

13. Evaluation of 2024 Turkish Medical Oncology Board Exam with ChatGPT

Kahraman E. G., ÜNAL O. Ü.

Journal of Oncological Science , cilt.11, sa.1, ss.36-39, 2025 (Scopus, TRDizin)

14. Prevalence of Insomnia and Associated Factors in Female Patients Undergoing Chemotherapy

TAŞKAYNATAN H., Ersoz B., Camanli U., Gezici B., Arslan Tan F., Mercan K., et al.

Nature and Science of Sleep , cilt.17, ss.2517-2528, 2025 (SCI-Expanded, Scopus)

15. Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study

Beypınar İ., Demir H., YASLIKAYA Ş., KÖŞECİ T., Demir B., Çolak G., et al.

Breast Cancer Research and Treatment , cilt.208, sa.3, ss.597-604, 2024 (SCI-Expanded, Scopus)

16. Impact of HER2-Low Status in Metastatic Gastric Cancer: A Real-World Retrospective Cohort Study

ÜNAL O. Ü., Akay S., Gul G., Keser M., Ozamrak B. G., SOLAKOĞLU KAHRAMAN D., et al.

Oncology (Switzerland) , cilt.102, sa.10, ss.889-896, 2024 (SCI-Expanded, Scopus)

17. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy

Kilickap S., Ozturk A., KARADURMUŞ N., KORKMAZ T., Yumuk P. F., Cicin I., et al.

Medicine (United States) , cilt.103, sa.21, 2024 (SCI-Expanded, Scopus)

18. Survival outcomes according to the tumor location and prognostic factor in metastatic rectal cancer: a multicenter retrospective cohort study

ÜNAL O. Ü., Akay S., SEMİZ H. S., Keser M., Demir G., Capar Z. G., et al.

Frontiers in Oncology , cilt.14, 2024 (SCI-Expanded, Scopus)

19. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Karacin C., Oksuzoglu B., Demirci A., Keskinkılıç M., Baytemür N. K., Yılmaz F., et al.

BMC Cancer , cilt.23, sa.1, 2023 (SCI-Expanded, Scopus)

20. The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

Akyildiz A., GÜVEN D. C., Ozluk A. A., Ismayilov R., Mutlu E., ÜNAL O. Ü., et al.

Medicine (United States) , cilt.102, sa.45, 2023 (SCI-Expanded, Scopus)

21. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Kahraman S., Erul E., Seyyar M., GÜMÜŞAY Ö., BAYRAM E., Demirel B. C., et al.

Future Oncology , cilt.19, sa.10, ss.727-736, 2023 (SCI-Expanded, Scopus)

22. Radiotherapy in Adjuvant Therapy in High-intermediate Risk and High Risk Endometrial Cancer: A Review Article Orta-yüksek Risk ve Yüksek Risk Endometrium Kanserinde Adjuvan Tedavide Radyoterapi: Derleme Makalesi

ERDOĞAN M., Güzelöz Z., Demir G., Ebruli C., Eyiler F., Keser M., et al.

Anatolian Journal of General Medical Research , cilt.33, sa.1, ss.7-11, 2023 (Scopus, TRDizin)

23. DPYD, TYMS and MTHFR genes polymorphism frequencies in a series of Turkish colorectal cancer patients

Amirfallah A., ÇALIBAŞI KOÇAL G., ÜNAL O. Ü., ELLİDOKUZ H., ÖZTOP İ., BAŞBINAR Y.

Journal of Personalized Medicine , cilt.8, sa.4, 2018 (Scopus)

24. Effective treatment of undiferentiated pleomorphic sarcoma using gemcitabine: A case report

ÜNAL O. Ü., Vardar E., Acar T., Vardar U., YILDIRIM M.

Turk Onkoloji Dergisi , cilt.33, sa.4, ss.162-165, 2018 (Scopus, TRDizin)

25. The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis

Bozcuk H., Abali H., Coskun S., Aydiner A., Çinkaya A., Demirkazik A., et al.

World Journal of Surgical Oncology , cilt.10, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Kitaplar 1

1. Systemic chemotherapy in colorectal cancer

ÜNAL O. Ü., Keser M., Akagündüz B.

Colon Polyps and Colorectal Cancer: Second Edition, Springer International Publishing Ag, ss.693-705, 2020

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

116

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler